Search clinical trials for: Long-Term Extension (LTE)

Total 2471 results

Eli Lilly and Company

Completed

Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)

Attention Deficit Hyperactivity Disorder

Japan
Alkermes, Inc.

Completed

ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)

Alcohol Dependence
Ferring Pharmaceuticals

Completed

Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer

Prostate Cancer

Finland, Belgium, Netherlands, Russian Federation, Germany, Romania, United Kingdom, France, Montenegro, Serbia
Texas AgriLife Extension Service
Texas A&M University

Completed

¡Si, Yo Puedo Control Mi Diabetes!: A Diabetes Self-management Education Program for Hispanic/Latinos (Yo Puedo)

Type 2 Diabetes, Hispanic/Latinos, Diabetes Self-management Education
Sanofi

Completed

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year (EPLILONG)

Insomnia | Sleep Initiation and Maintenance Disorders

United States, France, Germany, Netherlands, Spain, Czech Republic, Mexico, United Kingdom, Argentina, Austria, Finland, Chile, Canada, Australia
Alkermes, Inc.

Terminated

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])

Alcoholism | Opiate Dependence
Scios, Inc.

Completed

Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma

Multiple Myeloma
Ferring Pharmaceuticals

Completed

Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

Prostate Cancer

United States, Canada
Eli Lilly and Company

Completed

Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Australia, Greece, India, Netherlands, Poland, Puerto Rico
American Society for Gastrointestinal Endoscopy
Midwest Biomedical Research Foundation

Unknown

Cap Assisted Colonoscopy for the Detection of Colon Polyps

Adenoma | Colon Cancer | Colon Polyps

United States
Solvay Pharmaceuticals

Completed

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Advanced Stage Parkinson's Disease

United States, Albania, Argentina, Brazil, Bulgaria, Canada, Chile, Colombia, Latvia, Lithuania, Peru, Russian Federation, Ukraine
GlaxoSmithKline

Completed

Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Benign Prostatic Hyperplasia
Phenomix

Terminated

Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Argentina, Canada, Mexico, India
University of Oxford
Department of Health, United Kingdom; NHS Cancer Screening Programmes

Completed

Pilot Study: Age Extension of NHS Breast Screening Programme

Routine Mammography
Merz Pharmaceuticals GmbH

Terminated

Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus

Multiple Sclerosis | Nystagmus, Congenital | Nystagmus, Acquired

United Kingdom
University of Sydney

Completed

Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study

Diabetic Macular Oedema

Australia
BioLineRx, Ltd.

Completed

Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020

Schizophrenia

United States
Takeda

Completed

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

Chronic Insomnia

United States, Australia, France, Germany, Belgium, Finland, Russian Federation, Italy, Czech Republic
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; United States... and other collaborators

Unknown

Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer

Prostate Cancer

United States
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems

HIV Infections

United States, Puerto Rico
National Institute of Diabetes and Digestive and...

Completed

Long-Term Exercise Maintenance Via Internet Support

Obesity | Inactivity

United States
Shaare Zedek Medical Center

Unknown

Safety and Effectiveness of Tramadex-OD After Knee Arthroscopy

Postoperative Pain

Israel
GlaxoSmithKline

Completed

Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension

Hypertriglyceridemia
German Research Foundation

Unknown

Force Enhancement of Musculus Quadriceps Femoris During and After Excentric Muscle Activity in Vivo

Healthy | Muscle Quadriceps Femoris

Germany
Novartis Pharmaceuticals

Completed

Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole

Breast Cancer

Mexico
Pfizer

Terminated

Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Japan
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Effectiveness of Combining Light and Non-Light Treatments for Jet Lag and Sleep Disorders

Sleep Disorders, Circadian Rhythm

United States
BioMarin Pharmaceutical

Completed

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

Phenylketonurias

United States
Fondazione Poliambulanza Istituto Ospedaliero

Completed

Fluid Responsiveness Prediction at the Bedside

Shock | Hypotension

Italy
Logan College of Chiropractic

Unknown

Effect of Orthopedic Blocking on Cervical Spine Flexion and Extension Strength

Sacroiliac Function

United States
Biogen

Completed

Open-Label Natalizumab Safety Extension Study

Multiple Sclerosis

United States
Sanofi

Terminated

Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients (MODERATO)

Obesity | Weight Loss

Romania, Netherlands, Croatia, Finland, Hungary
Ullevaal University Hospital

Unknown

Long-Term Outcome Following Laparoscopic Supracervical Hysterectomy Performed With and Without Excision of the Endocervix in a Reverse Cone Pattern (LSH-LAPCONE)

Vaginal Bleeding

Norway
Biogen

Completed

Open-Label Safety Extension Study of Avonex

Multiple Sclerosis
Ambrilia Biopharma, Inc.

Completed

Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients

Acromegaly

Belarus, Hungary, Serbia, Ukraine, Romania, Slovakia
University Hospital Freiburg

Unknown

Long-Term Safety of Drug Eluting Stents in the "Real World" (FReIburger STent Registry) (FRIST)

Stent Thrombosis
Endo Pharmaceuticals

Completed

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

Lower Back Pain | Cancers, Pain

United States
AstraZeneca

Completed

Open-Label Extension of Other SZ1839 (Iressa) Trials

Cancer
Calliditas Therapeutics AB
Archimedes Development Ltd

Completed

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

IGA Nephropathy

Sweden
French Innovative Leukemia Organisation
Amgen

Completed

Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas (073)

Lymphoma

France
IDEA AG

Completed

IDEA-033 Three Months Dose Finding in OA Followed by IDEA-033 Three Months Extension in OA

Osteoarthritis; Knee
Sanofi

Completed

TREAD-20 Extension - Treatment of Knee Pain Due to Osteoarthritis

Osteoarthritis

United States
Abbott

Completed

Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent

HIV Infections

United States
Teva GTC

Terminated

One Year Extension Study To Protocol C2/5/TZ:MS-05

Multiple Sclerosis | Spasticity

Israel
University of Luebeck

Unknown

Long-Term Follow-up After the Autograft Aortic Valve Procedure (Ross Operation)

Aortic Valve Disease

Germany
Solvay Pharmaceuticals

Completed

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

Early Stage Parkinson's Disease

United States, Australia, Czech Republic, Estonia, Germany, India, Italy, Lithuania, Malaysia, Netherlands, Poland, Portugal, South Africa, Taiwan, Thailand
University of Wuerzburg
Schering-Plough

Completed

Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C

Hepatitis C, Chronic

Germany
Solvay Pharmaceuticals

Completed

An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

Early Stage Parkinson's Disease

United States, Argentina, Belgium, Bulgaria, Canada, Chile, Colombia, Croatia, Finland, India, Israel, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, Slovakia, South Africa, Sweden, Ukraine
Novartis

Completed

Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Japan
Radboud University Medical Center
Ipsen

Unknown

Open-Label Extension of LOCKCYST Trial (LOCKCYST-ext)

Liver Diseases | Hepatomegaly | Polycystic Liver Disease | Polycystic Kidney | Autosomal Dominant

Netherlands, Belgium

Search clinical trials for: Long-Term Extension (LTE)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations